Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease

M. Krishna, B. Woda, L. Savas, S. Baker, B. Banner

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Physiologic overexpression of p53 protein may occur in the G1 stage of the cell cycle to slow down the cell cycle and allow DNA repair in stressed or injured cells. We questioned whether there is increased expression of p53 protein in acutely inflamed mucosa (AT) and regenerated mucosa (RM) in ulcerative colitis (UC) and Crohn's disease (CD). Formalin-fixed paraffin-embedded sections of resected bowels from eight patients with UC and 20 with CD were reviewed, and blocks were selected having areas defined as follows: AI = two high-power fields (HPFs) at the edge of an ulcer, or one HPF with an inflamed crypt in the center; RM = branched or irregular glands with only mild chronic inflammation. Blocks with normal mucosa were available in 20 cases. One case of CD also had dysplasia, adenoma, and invasive carcinoma. p53 was identified with PAb1801 antibody using a labeled avidin-biotin immunoperoxidase technique. In each defined area, the positive nuclei were counted and expressed as the number of positive nuclei per 10 HPFs. Data were analyzed statistically for comparisons within and between the diseases. In normal mucosa, only rare cells expressed p53 in two cases of CD. The mean frequency of positive nuclei was 2.24/10 HPFs in AI and 0.30/10 HPFs in RM in CD, and 7.63/10 HPFs in AI and 1.14/10 HPFs in RM in UC. Differences between the means for AI and RM were statistically significant in both UC and CD. Although not significant, the frequency of positive staining in both AI and RM was greater in UC as compared with CD. The results show that p53 expression is increased in areas of acute inflammation in UC and CD. Decreased expression in RM as compared with AI suggests that expression of p53 is reversible and gene regulation in these areas is different.

Original languageEnglish (US)
Pages (from-to)654-657
Number of pages4
JournalModern Pathology
Volume8
Issue number6
StatePublished - 1995

Fingerprint

Tumor Suppressor Protein p53
Ulcerative Colitis
Crohn Disease
Mucous Membrane
Cell Cycle
Inflammation
Avidin
Biotin
Immunoenzyme Techniques
DNA Repair
Adenoma
Paraffin
Formaldehyde
Ulcer
Proteins
Staining and Labeling
Carcinoma

Keywords

  • Crohn's disease
  • Immunohistochemistry
  • P53
  • Ulcerative colitis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Krishna, M., Woda, B., Savas, L., Baker, S., & Banner, B. (1995). Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Modern Pathology, 8(6), 654-657.

Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. / Krishna, M.; Woda, B.; Savas, L.; Baker, S.; Banner, B.

In: Modern Pathology, Vol. 8, No. 6, 1995, p. 654-657.

Research output: Contribution to journalArticle

Krishna, M, Woda, B, Savas, L, Baker, S & Banner, B 1995, 'Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease', Modern Pathology, vol. 8, no. 6, pp. 654-657.
Krishna, M. ; Woda, B. ; Savas, L. ; Baker, S. ; Banner, B. / Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. In: Modern Pathology. 1995 ; Vol. 8, No. 6. pp. 654-657.
@article{03cbd9c9b18241389952a274bdad8506,
title = "Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease",
abstract = "Physiologic overexpression of p53 protein may occur in the G1 stage of the cell cycle to slow down the cell cycle and allow DNA repair in stressed or injured cells. We questioned whether there is increased expression of p53 protein in acutely inflamed mucosa (AT) and regenerated mucosa (RM) in ulcerative colitis (UC) and Crohn's disease (CD). Formalin-fixed paraffin-embedded sections of resected bowels from eight patients with UC and 20 with CD were reviewed, and blocks were selected having areas defined as follows: AI = two high-power fields (HPFs) at the edge of an ulcer, or one HPF with an inflamed crypt in the center; RM = branched or irregular glands with only mild chronic inflammation. Blocks with normal mucosa were available in 20 cases. One case of CD also had dysplasia, adenoma, and invasive carcinoma. p53 was identified with PAb1801 antibody using a labeled avidin-biotin immunoperoxidase technique. In each defined area, the positive nuclei were counted and expressed as the number of positive nuclei per 10 HPFs. Data were analyzed statistically for comparisons within and between the diseases. In normal mucosa, only rare cells expressed p53 in two cases of CD. The mean frequency of positive nuclei was 2.24/10 HPFs in AI and 0.30/10 HPFs in RM in CD, and 7.63/10 HPFs in AI and 1.14/10 HPFs in RM in UC. Differences between the means for AI and RM were statistically significant in both UC and CD. Although not significant, the frequency of positive staining in both AI and RM was greater in UC as compared with CD. The results show that p53 expression is increased in areas of acute inflammation in UC and CD. Decreased expression in RM as compared with AI suggests that expression of p53 is reversible and gene regulation in these areas is different.",
keywords = "Crohn's disease, Immunohistochemistry, P53, Ulcerative colitis",
author = "M. Krishna and B. Woda and L. Savas and S. Baker and B. Banner",
year = "1995",
language = "English (US)",
volume = "8",
pages = "654--657",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease

AU - Krishna, M.

AU - Woda, B.

AU - Savas, L.

AU - Baker, S.

AU - Banner, B.

PY - 1995

Y1 - 1995

N2 - Physiologic overexpression of p53 protein may occur in the G1 stage of the cell cycle to slow down the cell cycle and allow DNA repair in stressed or injured cells. We questioned whether there is increased expression of p53 protein in acutely inflamed mucosa (AT) and regenerated mucosa (RM) in ulcerative colitis (UC) and Crohn's disease (CD). Formalin-fixed paraffin-embedded sections of resected bowels from eight patients with UC and 20 with CD were reviewed, and blocks were selected having areas defined as follows: AI = two high-power fields (HPFs) at the edge of an ulcer, or one HPF with an inflamed crypt in the center; RM = branched or irregular glands with only mild chronic inflammation. Blocks with normal mucosa were available in 20 cases. One case of CD also had dysplasia, adenoma, and invasive carcinoma. p53 was identified with PAb1801 antibody using a labeled avidin-biotin immunoperoxidase technique. In each defined area, the positive nuclei were counted and expressed as the number of positive nuclei per 10 HPFs. Data were analyzed statistically for comparisons within and between the diseases. In normal mucosa, only rare cells expressed p53 in two cases of CD. The mean frequency of positive nuclei was 2.24/10 HPFs in AI and 0.30/10 HPFs in RM in CD, and 7.63/10 HPFs in AI and 1.14/10 HPFs in RM in UC. Differences between the means for AI and RM were statistically significant in both UC and CD. Although not significant, the frequency of positive staining in both AI and RM was greater in UC as compared with CD. The results show that p53 expression is increased in areas of acute inflammation in UC and CD. Decreased expression in RM as compared with AI suggests that expression of p53 is reversible and gene regulation in these areas is different.

AB - Physiologic overexpression of p53 protein may occur in the G1 stage of the cell cycle to slow down the cell cycle and allow DNA repair in stressed or injured cells. We questioned whether there is increased expression of p53 protein in acutely inflamed mucosa (AT) and regenerated mucosa (RM) in ulcerative colitis (UC) and Crohn's disease (CD). Formalin-fixed paraffin-embedded sections of resected bowels from eight patients with UC and 20 with CD were reviewed, and blocks were selected having areas defined as follows: AI = two high-power fields (HPFs) at the edge of an ulcer, or one HPF with an inflamed crypt in the center; RM = branched or irregular glands with only mild chronic inflammation. Blocks with normal mucosa were available in 20 cases. One case of CD also had dysplasia, adenoma, and invasive carcinoma. p53 was identified with PAb1801 antibody using a labeled avidin-biotin immunoperoxidase technique. In each defined area, the positive nuclei were counted and expressed as the number of positive nuclei per 10 HPFs. Data were analyzed statistically for comparisons within and between the diseases. In normal mucosa, only rare cells expressed p53 in two cases of CD. The mean frequency of positive nuclei was 2.24/10 HPFs in AI and 0.30/10 HPFs in RM in CD, and 7.63/10 HPFs in AI and 1.14/10 HPFs in RM in UC. Differences between the means for AI and RM were statistically significant in both UC and CD. Although not significant, the frequency of positive staining in both AI and RM was greater in UC as compared with CD. The results show that p53 expression is increased in areas of acute inflammation in UC and CD. Decreased expression in RM as compared with AI suggests that expression of p53 is reversible and gene regulation in these areas is different.

KW - Crohn's disease

KW - Immunohistochemistry

KW - P53

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=0029028826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029028826&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 654

EP - 657

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 6

ER -